PetMed Express (PETS) to Release Quarterly Earnings on Wednesday

PetMed Express (NASDAQ:PETS) will release its earnings data after the market closes on Wednesday, November 6th. Analysts expect PetMed Express to post earnings of ($0.06) per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

PetMed Express (NASDAQ:PETS) last posted its earnings results on Tuesday, August 6th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.30. The company had revenue of $67.95 million for the quarter, compared to analyst estimates of $77.52 million. PetMed Express had a negative net margin of 1.24% and a negative return on equity of 3.44%. On average, analysts expect PetMed Express to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

PetMed Express Trading Up 2.2 %

Shares of PetMed Express stock opened at $4.19 on Monday. PetMed Express has a 12 month low of $2.90 and a 12 month high of $8.27. The company has a market capitalization of $86.31 million, a PE ratio of -24.65 and a beta of 0.68. The stock’s fifty day simple moving average is $3.69 and its 200 day simple moving average is $3.87.

Wall Street Analyst Weigh In

Separately, Lake Street Capital reaffirmed a “hold” rating and issued a $3.50 price target (down previously from $7.00) on shares of PetMed Express in a research note on Wednesday, August 7th.

Insiders Place Their Bets

In other news, major shareholder Nina Capital Holdings Inc. acquired 12,500 shares of PetMed Express stock in a transaction dated Monday, September 9th. The stock was bought at an average cost of $3.34 per share, with a total value of $41,750.00. Following the completion of the transaction, the insider now directly owns 2,078,000 shares of the company’s stock, valued at approximately $6,940,520. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.10% of the company’s stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.